United States of America Canada United States of America Mexico Bermuda St. Pierre et Miquelon St. Pierre et Miquelon Greenland Panama Aruba Barbados Bermuda Turks & Caicos Islands Cayman Islands Guatemala Belize Bahamas Haiti Costa Rica Puerto Rico Puerto Rico US Virgin Islands US Virgin Islands British Virgin Islands Trinidad & Tobago Netherlands Antilles Cuba Jamaica United States (Minor Outlying Islands) Dominican Republic Grenada St. Vincent & the Grenadines St. Lucia Martinique Dominica Guadeloupe Montserrat Antigua & Barbuda St. Kitts & Nevis Anguilla Nicaragua El Salvador Honduras Venezuela Ecuador Peru Chile Uruguay Colombia Suriname French Guiana Guyana Bolivia Paraguay Brazil Argentina South Georgia Falkland Islands Djibouti Eritrea Somalia Ethiopia Egypt Sudan Libya Tunisia Algeria Mauritania Gambia Gambia Senegal Burkina Faso Niger Mali Guinea-Bissau Guinea-Bissau Guinea Sierra Leone Sierra Leone Cote d'Ivoire Liberia Liberia Ghana Ghana Togo Togo Benin Benin Nigeria Cameroon Central African Republic Uganda Kenya Sao Tome & Principe Sao Tome & Principe Equatorial Guinea Equatorial Guinea Gabon Congo (Brazzaville) Congo, Democratic Republic Rwanda Burundi Rwanda Burundi Tanzania Angola Malawi Zambia Namibia Zimbabwe Botswana Swaziland Mozambique Malawi Lesotho Lesotho Madagascar Comoros Mauritius South Africa Chad Cape Verde Islands Seychelles Reunion St. Helena Morocco Western Sahara Portugal Spain Yemen Comoros Mayotte Mayotte Kuwait Qatar Bahrain Iran Cyprus Jordan Saudi Arabia Syria Egypt Armenia Turkey United Arab Emirates Oman Yemen Iraq Georgia Azerbaijan Lebanon Palestinian Authority Palestinian Authority Israel Azerbaijan Nepal Bhutan China North Korea South Korea Macao Brunei East Timor Singapore Singapore Laos Russia Japan Sri Lanka Hong Kong Philippines Malaysia Indonesia Kazakhstan Kyrgyzstan Uzbekistan Turkmenistan Tajikistan Afghanistan Mongolia Maldives China Pakistan India Bangladesh Thailand Burma (Myanmar) Laos Cambodia Cambodia Taiwan (Republic of China) Vietnam Christmas Island Cocos (Keeling) Islands British Indian Ocean Territory Australia New Zealand New Caledonia Vanuatu Fiji Tonga Hawai Pitcairn Island American Samoa Northern Marianas Islands Guam United States (Minor Outlying Islands) United States (Minor Outlying Islands) United States (Minor Outlying Islands) United States (Minor Outlying Islands) United States (Minor Outlying Islands) Nauru Tokelau Wallis & Futuna Islands Palau Samoa Niue Cook Islands Tuvalu Solomon Islands Australia Papua New Guinea Micronesia Marshall Islands Kiribati Norfolk Island French Polynesia Malta San Marino San Marino Andorra Andorra Liechtenstein Liechtenstein Faroe Islands Guernsey Guernsey Jersey Jersey Gibraltar Georgia Iceland Ireland United Kingdom Portugal Monaco Spain France Vatican City State (Holy See) Switzerland Belgium Netherlands Luxembourg Germany Denmark Norway Aland Islands Sweden Finland Czech Republic Austria Slovenia Italy Slovenia Croatia Croatia Slovakia Hungary Poland Serbia Macedonia Greece Cyprus Bulgaria Turkey Russia Lithuania Latvia Estonia Ukraine Russia Moldova Moldova Romania Bosnia & Herzegovina Bosnia & Herzegovina Belarus Albania Svalbard & Jan Mayen Islands Isle of Man Isle of Man Aland Islands Armenia Azerbaijan Azerbaijan Kazakhstan Montenegro
Home  |  Recent Documents   |  Add New Document   |  Search   |  Contact
You are logged out. Click here to Login  or Create New Account .
World
North America
South America
Central America
Europe
Asia
Africa
Middle East
Australia/Oceania
 
All Others
Most Active:
European Union (182)
United States of America (80)
United Kingdom (39)
Australia (34)
Germany (25)
NGOs (15)
European Union
International Standa...
NGOs
United Nations

Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Falkland Islands
French Guiana
Guyana
Paraguay
Peru
South Georgia
Suriname
Uruguay
Venezuela
Guyana
Department of Health and Ageing, Therapeutic Goods Administration (Australian government)


Report Title: Attachment 7: Proposed Model for a Mandatory Notification and Assessment
Report ID: 424
Date: 11/1/2009
Author: National Industrial Chemicals Assessment and Notification Scheme
Report Type: Background Document
URL: [Attachment_7_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: The following attachment contains a proposed model for the mandatory notification and assessment program as described in NICNAS’s Proposal for Regulatory Reform of Industrial Nanomaterials Public Discussion Paper.
Archived Copy: Attachment_7_PDF_424_2615.pdf



Report Title: Attachment 6: Proposed Strategy for Nano-forms of New-chemicals
Report ID: 423
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment Scheme
Report Type: Background Document
URL: [Attachment_6_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: The following attachment contains tables and drawings that illustrate the current regulatory framework for industrial nanomaterials in Australia. Elaborated, this consists of the provisions for new chemicals used in research and development under The Industrial Chemicals Notification and Assessment Act 1989, a summary of the permit categories for regulation of industrial nanomaterials under NICNAS, the proposal for regulation of industrial nanomaterials under NICNAS certificate categories, and a proposed strategy for requesting particle size distribution information for permit and certificate categories.
Archived Copy: Attachment_6_PDF_423_6363.pdf



Report Title: Attachment 5: Overview of NICNAS New Chemical Notification Categories
Report ID: 422
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment
Report Type: Background Document
URL: [Attachment_5_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: This attachment contains an overview of NICNAS two new chemical notification categories. The first, permit notification, is suitable for chemicals which meet certain criteria and result in the issue of a permit allowing the introduction of fixed quantities of the chemical for the duration of the permit. The certificate notification, which is the second, is intended for chemicals which do not meet the permit criteria or where the introducer prefers a certificate notification to a permit notification. Certificate categories result in an assessment report, the issue of an assessment certificate, and public publication of the assessed chemical. Additionally, a chemical that has been formally assessed by NICNAS, either as a new or existing chemical, may necessitate a secondary notification assessment due to changed circumstances. The procedure for such reassessment is set in place by Section 64 of the Industrial Chemicals (Notification and Assessment) Act (1989).
Archived Copy: Attachment_5_PDF_422_5015.pdf



Report Title: Attachment 4: Overview of International Activities Addressing Regulation of Industrial Nanomaterials
Report ID: 421
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment
Report Type: Background Document
URL: [Attachment_4_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: The following attachment contains overviews of the regulation of industrial nanomaterials from the United States, Canada, the United Kingdom, and the European Union’s REACH regulatory schema.
Archived Copy: Attachment_4_PDF_421_7062.pdf



Report Title: Attachment 3: Summary of Findings from Review of the Possible Impacts of Nanotechnology on Australia’s Regulatory Framework
Report ID: 420
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment Scheme
Report Type: Background Document
URL: [Attachment_3_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: Australia’s federal regulatory frameworks are generally well suited to allowing adequate management and control of risks posed by engineered nanomaterials (NM) and products incorporating NM, and their manufacture, use and handling. This review found that there was no case where a particular regulatory framework generally did not apply to a nanofamily as a result of the presence of NMs. Further, the application generally of the federal regulatory frameworks to NMs and products in the nanofamilies meant that regulation throughout the whole of the lifecycle of these materials is largely the same as for conventional products. However, the general repercussions of such applications were also the same as for conventional products; some regulatory regimes involve regulatory approval prior to undertaking the particular regulated activity. This, in tur, meant that steps not required to be taken under particular regulatory frameworks were also not taken for NMs. Nevertheless, some gaps were found where the regulatory frameworks either do not apply at all to NMs and products incorporating them or do not apply to NMs or nanoproducts as appropriately as they apply to conventional products in the same families.
Archived Copy: Attachment_3_PDF_420_2280.pdf



Report Title: Attachment 2 - Indicative List of Nanomaterials.
Report ID: 419
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment Scheme
Report Type: Background Document
URL: [Attachment_2_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: This attachment contains an indicative, but by no means exhaustive, list of substances that the National Industrial Chemicals Notification and Assessment Scheme considers to be produced as industrial nanomaterials.
Archived Copy: Attachment_2_PDF_419_9730.pdf



Report Title: Attachment 1: Overarching Principles of the NICNAS Regulatory Strategy
Report ID: 418
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment Scheme
Report Type: Background Document
URL: [Attachment_1_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: This attachment highlights essential principles for managing the risks posed by new technologies (including nanotechnology) to health and safety of people and the environment. Chief among them is reviewing the ability of the existing regulatory framework to deliver an efficient and effective response to the new technology while also being mindful that any risk from use of the nano-form of a chemical is no greater than that posed by the conventional form of the chemical or it is at or below the level of acceptable risk. Equally important is a second principle, that in managing risk one should make use of the best scientific evidence available for risk based assessment of the impacts of the new technology on human health and the environment, including the ability to review decisions as new scientific evidence becomes available. Finally, where best available scientific evidence is insufficient to support the safety of the product/chemical, measures to protect public health and safety and the environment can be adopted.
Archived Copy: Attachment_1_PDF_418_7501.pdf



Report Title: Proposal for Regulatory Reform of Industrial; Public Discussion Paper
Report ID: 413
Date: 11/1/2009
Author: National Industrial Chemicals Notification and Assessment Scheme
Report Type: Concept Paper
URL: [NICNAS_Nano_PUBLIC_DISCUSSION_PAPER_PDF.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: This paper provides NICNAS’s stakeholders (the community, industry and government) with the opportunity to comment to NICNAS on a reform initiative to introduce new approaches to the regulation of industrial nanomaterials. The proposal utilizes the existing NICNAS framework, and proposes some adjustments to address uncertainties in potential risks posed by these novel materials to health, safety and the environment. The proposal addresses three elements: regulation of nanoforms of new chemicals, regulation of nanoforms of existing chemicals, and the principle of an integrated approach for industrial nanomaterials within the NICNAS framework as a longer term strategy. As part of this paper, NICNAS is seeking input from stakeholders regarding whether it provides for the sound management of industrial nanomaterials and whether it establishes a clear, regulatory framework for ensuring public health, worker safety, and environmental standards.
Archived Copy: NICNAS_Nano_PUBLIC_DISCUSSION_PAPER_PDF_413_8973.pdf



Report Title: Updated Arrangements for Approved Uv Filters and Assessment of New Uv Filters Used in Cosmetics
Report ID: 165
Date: 10/7/2008
Author: Government of Australia: Department of Ageing and National Industrial Chemical Notification and Assessment Scheme
Report Type: Guidance Document
URL: [2008oct_whole.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: The purpose of this notice is to advise companies of the notification and assessment requirements for UV filters in cosmetic products that fall within the scope of the Industrial Chemicals Notification and Assessment Act 1989. The National Industrial Chemical Notification and Assessment Scheme (NICNAS) had received enquiries regarding the notification requirements for UV filters in cosmetic products. In January 2007 NICNAS published in the Chemical Gazette a notice describing new arrangements for UV filters proposed for use in cosmetic products as well as products covered under the former Cosmetic Interim Arrangement. These legislative changes resulted in the introduction of a Cosmetic Standard which describes the regulatory requirements for six cosmetic product categories with much attention placed on product categories containing sunscreens.



Archived Copy: 2008oct_whole_165_2476.pdf



Report Title: A review of the scientific literature on the safety of nanoparticulate titanium dioxide or zinc oxide in sunscreens
Report ID: 121
Date: 1/16/2006
Report Type: Summary Article
URL: [sunscreen-zotd.pdf]
Country: Australia
Organization: Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
Summary: This Australian government article summarizes existing research regarding the safety of nanoparticle sunscreens containing zinc oxide or titanium dioxide. The use of nanoparticles on the human skin has been identified as potentially dangerous. This document summarizes 24 scientific studies relating to nanoparticles and the skin. It finds some studies linking exposure to zinc oxide and titanium dioxide to free radical production and adverse effects. Other studies involving dermal penetration found that these nanoparticles did not penetrate into lower levels of the skin. Based upon the research summarized, the report concludes that nanoparticles in sunscreens remain on the surface (outer dead layer) of the skin and thus do not pose a health hazard.



 
Maps and boundary data are copyrighted by
FOTW - Flags Of The World web site